We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Routine Blood Glucose Measurements Can Accurately Estimate HbA1c

By LabMedica International staff writers
Posted on 06 May 2014
Glycated hemoglobin or HbA1c is the standard measurement for assessing glycemic control over time in people with diabetes and blood levels of HbA1c are typically measured every few months in a laboratory.

The relationship between HbA1c and average glucose levels could determine whether HbA1c could be expressed and reported as average glucose in the same units as used in self-monitoring which could increase individuals' motivation to improve diabetes control. More...


Scientists at the University of Virginia (Charlottesville, VA, USA) working with those at Sanofi-Aventis Deutschland GmbH (Frankfurt, Germany) developed a data-based model that accurately estimates HbA1c using self-monitored blood glucose (SMBG) readings. The computer algorithm they developed was based on a training data set drawn from 379 subjects and then evaluated for accuracy on an independent test data set. The average HbA1c level was 7.6% (± 1.1%), with minimum and maximum values of 5.2% and 12.2%, respectively.

A conceptually new, clinically viable procedure was developed for real-time tracking of average glycaemia from self-monitoring data. The average glucose tracing can then be converted into running estimates of HbA1c, which can be presented to the patient daily. The computational demands of the procedure are low and therefore readily implementable into devices with limited processing power, such as home SMBG meter.

The procedure, tracking average glycaemia and HbA1c in real time, could provide valuable assistance to the daily optimization of diabetes control. The procedure is not intended as a substitute for laboratory assessments of HbA1c and it should be viewed as a surrogate measure that allows convenient tracing of average glucose, readily implementable in a point-of-care SMBG device.

Satish Garg, MD, a professor of medicine and pediatrics at the University of Colorado (Denver, CO, USA) said, “Patients are used to a HbA1c result from their doctor visits, and this study highlights simple estimated HbA1c values from SMBG data. This may become an important tool for improved patient self-management.” The study was published on April 23, 2014, in the journal Diabetes Technology & Therapeutics.

Related Links:

University of Virginia 
Sanofi-Aventis Deutschland GmbH 
University of Colorado



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Pan-Cancer Panel
TruSight Oncology 500
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.